Fibroblasts in Diabetic Foot Ulcers

Area of Science:

• Cell Biology
• Tissue Engineering
• Regenerative Medicine

Background:

• Fibroblasts are ubiquitous stromal cells historically viewed as passive matrix maintainers.
• Recent technological advances reveal fibroblast plasticity, heterogeneity, and multifaceted roles in tissue homeostasis.
• Fibroblast dysregulation is implicated in major chronic diseases, including cardiovascular disease, cancer, and diabetes mellitus.

Purpose of the Study:

• To highlight the critical role of fibroblasts in wound healing.
• To underscore the significance of fibroblast dysregulation in chronic diseases, particularly diabetic foot ulcers (DFU).
• To emphasize the need for a deeper understanding of DFU pathophysiology for therapeutic development.

Main Methods:

• Review of recent technological innovations (genetically modified mouse models, single-cell analysis).
• Analysis of fibroblast functions including phenotype switching, angiogenesis, inflammation, and stemness.
• Examination of the link between fibroblast dysregulation and chronic conditions.

Main Results:

• Fibroblasts exhibit remarkable plasticity and heterogeneity, actively regulating tissue repair.
• These cells play central roles in wound healing through angiogenesis, inflammation modulation, and inherent stemness.
• Dysfunctional fibroblasts contribute significantly to the pathophysiology of chronic diseases like DFU.

Conclusions:

• Fibroblasts are dynamic regulators of tissue integrity and wound healing.
• Targeting fibroblast pathways offers a promising therapeutic avenue for chronic non-healing wounds like DFU.
• Further research into fibroblast pathophysiology is essential for developing effective DFU treatments.